Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Ellagic Acid Inhibits Migration and Invasion by Prostate Cancer Cell Lines

  • Pitchakarn, Pornsiri (Department of Biochemistry, Faculty of Medicine, Chiang Mai University) ;
  • Chewonarin, Teera (Department of Biochemistry, Faculty of Medicine, Chiang Mai University) ;
  • Ogawa, Kumiko (Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of Medical Sciences) ;
  • Suzuki, Shugo (Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of Medical Sciences) ;
  • Asamoto, Makoto (Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of Medical Sciences) ;
  • Takahashi, Satoru (Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of Medical Sciences) ;
  • Shirai, Tomoyuki (Department of Experimental Pathology and Tumor Biology, Nagoya City University, Graduate School of Medical Sciences) ;
  • Limtrakul, Pornngarm (Department of Biochemistry, Faculty of Medicine, Chiang Mai University)
  • Published : 2013.05.30
Download PDF
⟨ Previous Next ⟩

Abstract

Polyphenolic compounds from pomegranate fruit extracts (PFEs) have been reported to possess antiproliferative, pro-apoptotic, anti-inflammatory and anti-invasion effects in prostate and other cancers. However, the mechanisms responsible for the inhibition of cancer invasion remain to be clarified. In the present study, we investigated anti-invasive effects of ellagic acid (EA) in androgen-independent human (PC-3) and rat (PLS10) prostate cancer cell lines in vitro. The results indicated that non-toxic concentrations of EA significantly inhibited the motility and invasion of cells examined in migration and invasion assays. The EA treatment slightly decreased secretion of matrix metalloproteinase (MMP)-2 but not MMP-9 from both cell lines. We further found that EA significantly reduced proteolytic activity of collagenase/gelatinase secreted from the PLS-10 cell line. Collagenase IV activity was also concentration-dependently inhibited by EA. These results demonstrated that EA has an ability to inhibit invasive potential of prostate cancer cells through action on protease activity.

Keywords

References

  1. Azzam HS, Thompson EW (1992). Collagen-induced activation of the M(r) 72,000 type IV collagenase in normal and malignant human fibroblastoid cells. Cancer Res, 52, 4540-4.
  2. Bell C, Hawthorne S (2008). Ellagic acid, pomegranate and prostate cancer -- a mini review. J Pharm Pharmacol, 60, 139-44. https://doi.org/10.1211/jpp.60.2.0001
  3. Bianco FJ Jr, Gervasi DC, Tiguert R, et al (1998). Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res, 4, 3011-6.
  4. Braun-Falco M, Holtmann C, Lordick F, et al (2006). Follicular drug reaction from cetuximab: a common side effect in the treatment of metastatic colon carcinoma. Hautarzt, 57, 701-4. https://doi.org/10.1007/s00105-005-0979-5
  5. Castonguay AGHU, Perchellet EM (1997). Antitumorigenic and antipromoting activities of ellagic acid, ellagitannins and oligometric anthocyanin and procyanidin. Int J Oncol, 10, 367-73.
  6. Cockett MI, Murphy G, Birch ML, et al (1998). Matrix metalloproteinases and metastatic cancer. Biochem Soc Symp, 63, 295-313.
  7. Fernandez-Patron C, Radomski MW, Davidge ST (1999). Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res, 85, 906-11. https://doi.org/10.1161/01.RES.85.10.906
  8. Fidler IJ, Kripke ML (1977). Metastasis results from preexisting variant cells within a malignant tumor. Science, 197, 893-5. https://doi.org/10.1126/science.887927
  9. Giancotti FG, Ruoslahti E (1999). Integrin signaling. Science, 285, 1028-32. https://doi.org/10.1126/science.285.5430.1028
  10. Gilles C, Polette M, Seiki M, et al (1997). Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma. Lab Invest, 76, 651-60.
  11. Gronberg H (2003). Prostate cancer epidemiology. Lancet, 361, 859-64. https://doi.org/10.1016/S0140-6736(03)12713-4
  12. Hamasaki K, Kogure K, Ohwada K (1996). A biological method for the quantitative measurement of tetrodotoxin (TTX): tissue culture bioassay in combination with a water-soluble tetrazolium salt. Toxicon, 34, 490-5. https://doi.org/10.1016/0041-0101(95)00151-4
  13. Han DH, Lee MJ, Kim JH (2006). Antioxidant and apoptosisinducing activities of ellagic acid. Anticancer Res, 26, 3601-6.
  14. Jemal A, Siegel R, Ward E, et al (2008). Cancer statistics, 2008. CA Cancer J Clin, 58, 71-96. https://doi.org/10.3322/CA.2007.0010
  15. Khanduja KL, Avti PK, Kumar S, et al (2006). Anti-apoptotic activity of caffeic acid, ellagic acid and ferulic acid in normal human peripheral blood mononuclear cells: a Bcl-2 independent mechanism. Biochim Biophys Acta, 1760, 283-9. https://doi.org/10.1016/j.bbagen.2005.12.017
  16. Lansky EP, Harrison G, Froom P, et al (2005). Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs, 23, 121-2. https://doi.org/10.1007/s10637-005-5856-7
  17. Larrosa M, Tomas-Barberan FA, Espin JC (2006). The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem, 17, 611-25. https://doi.org/10.1016/j.jnutbio.2005.09.004
  18. Lin SS, Lai KC, Hsu SC, et al (2009). Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and vascular endothelial growth gactor (VEGF). Cancer Lett, 285, 127-33. https://doi.org/10.1016/j.canlet.2009.04.037
  19. Liotta LA, Rao CN, Wewer UM (1986). Biochemical interactions of tumor cells with the basement membrane. Annu Rev Biochem, 55, 1037-57. https://doi.org/10.1146/annurev.bi.55.070186.005133
  20. Li TM, Chen GW, Su CC, et al (2005). Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res, 25, 971-9.
  21. Longtin R (2003). The pomegranate: nature's power fruit? J Natl Cancer Inst, 95, 346-8. https://doi.org/10.1093/jnci/95.5.346
  22. Mukhtar H, Das M, Khan WA, et al (1988). Exceptional activity of tannic acid among naturally occurring plant phenols in protecting against 7,12-dimethylbenz(a) anthracene-, benzo(a)pyrene-, 3-methylcholanthrene-, and N-methyl-N-nitrosourea-induced skin tumorigenesis in mice. Cancer Res, 48, 2361-5.
  23. Nagase H, Woessner JF, Jr. (1999). Matrix metalloproteinases. J Biol Chem, 274, 21491-4. https://doi.org/10.1074/jbc.274.31.21491
  24. Nakanishi H TS, Kato K, Shimizu S, et al (1996). Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats. Jpn J Cancer Res, 87, 1218-26. https://doi.org/10.1111/j.1349-7006.1996.tb03136.x
  25. Narayanan BA, Geoffroy O, Willingham MC, et al (1999). p53/p21(WAF1/CIP1) expression and its possible role in G1 arrest and apoptosis in ellagic acid treated cancer cells. Cancer Lett, 136, 215-21. https://doi.org/10.1016/S0304-3835(98)00323-1
  26. Papathoma AS, Zoumpourlis V, Balmain A, et al (2001). Role of matrix metalloproteinase-9 in progression of mouse skin carcinogenesis. Mol Carcinog, 31, 74-82. https://doi.org/10.1002/mc.1042
  27. Pitchakarn P, Ogawa K, Suzuki S, et al (2010). Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivo. Cancer Sci, 101, 2234-40. https://doi.org/10.1111/j.1349-7006.2010.01669.x
  28. Seeram NP, Adams LS, Henning SM, et al (2005). In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutr Biochem, 16, 360-7. https://doi.org/10.1016/j.jnutbio.2005.01.006
  29. Seeram NP, Henning SM, Zhang Y, et al (2006). Pomegranate juice ellagitannin metabolites are present in human plasma and some persist in urine for up to 48 hours. J Nutr, 136, 2481-5.
  30. Seeram NP, Aronson WJ, Zhang Y, et al (2007). Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem, 55, 7732-7. https://doi.org/10.1021/jf071303g
  31. Stetler-Stevenson WG (1990). Type IV collagenases in tumor invasion and metastasis. Cancer Metastasis Rev, 9, 289-303. https://doi.org/10.1007/BF00049520
  32. Stoner GD, Gupta A (2001). Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis, 22, 1737-46. https://doi.org/10.1093/carcin/22.11.1737
  33. Strati A, Papoutsi Z, Lianidou E, et al (2009). Effect of ellagic acid on the expression of human telomerase reverse transcriptase (hTERT) alpha+beta+ transcript in estrogen receptor-positive MCF-7 breast cancer cells. Clin Biochem, 42, 1358-62. https://doi.org/10.1016/j.clinbiochem.2009.05.017
  34. Thresiamma KC, Kuttan R (1996). Inhibition of liver fibrosis by ellagic acid. Indian J Physiol Pharmacol, 40, 363-6.
  35. Wang M, Wang T, Liu S, et al (2003). The expression of matrix metalloproteinase-2 and -9 in human gliomas of different pathological grades. Brain Tumor Pathol, 20, 65-72. https://doi.org/10.1007/BF02483449
  36. Westermarck J, Kahari VM (1999). Regulation of matrix metalloproteinase expression in tumor invasion. FASEB J, 13, 781-92.
  37. Yodkeeree S, Garbisa S, Limtrakul P (2008). Tetrahydrocurcumin inhibits HT1080 cell migration and invasion via downregulation of MMPs and uPA. Acta Pharmacol Sin, 29, 853-60. https://doi.org/10.1111/j.1745-7254.2008.00792.x
  38. Zeng ZS, Cohen AM, Guillem JG (1999). Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis. Carcinogenesis, 20, 749-55. https://doi.org/10.1093/carcin/20.5.749

Cited by

  1. New Insights into 4-Amino-2-tri-fluoromethyl-phenyl Ester Inhibition of Cell Growth and Migration in the A549 Lung Adenocarcinoma Cell Line vol.14, pp.12, 2013, https://doi.org/10.7314/APJCP.2013.14.12.7265
  2. Luteolin inhibits matrix metalloproteinase 9 and 2 in azoxymethane-induced colon carcinogenesis vol.33, pp.11, 2014, https://doi.org/10.1177/0960327114522502
  3. Melatonin inhibits the Migration of Colon Cancer RKO cells by Down-regulating Myosin Light Chain Kinase Expression through Cross-talk with p38 MAPK vol.16, pp.14, 2015, https://doi.org/10.7314/APJCP.2015.16.14.5835
  4. Efficacy and Safety of Pomegranate Medicinal Products for Cancer vol.2015, pp.1741-4288, 2015, https://doi.org/10.1155/2015/258598
  5. Effect of pomegranate peel polyphenols on human prostate cancer PC-3 cells in vivo vol.24, pp.5, 2015, https://doi.org/10.1007/s10068-015-0247-0
  6. Natural Polyphenols for Prevention and Treatment of Cancer vol.8, pp.8, 2016, https://doi.org/10.3390/nu8080515
  7. Multiple effects of ellagic acid on human colorectal carcinoma cells identified by gene expression profile analysis vol.50, pp.2, 2017, https://doi.org/10.3892/ijo.2017.3843
  8. Ellagic acid, a component of pomegranate fruit juice, suppresses androgen-dependent prostate carcinogenesis via induction of apoptosis vol.75, pp.2, 2015, https://doi.org/10.1002/pros.22900
  9. Dietary Polyphenols in Prevention and Treatment of Prostate Cancer vol.16, pp.2, 2015, https://doi.org/10.3390/ijms16023350
  10. Ellagic Acid Prevents L-NAME-Induced Hypertension via Restoration of eNOS and p47phox Expression in Rats vol.7, pp.7, 2015, https://doi.org/10.3390/nu7075222
  11. Experimental Evidence of the Antitumor, Antimetastatic and Antiangiogenic Activity of Ellagic Acid vol.10, pp.11, 2018, https://doi.org/10.3390/nu10111756
  12. Induction of apoptosis by in vitro and in vivo plant extracts derived from Menyanthes trifoliata L. in human cancer cells vol.71, pp.1, 2019, https://doi.org/10.1007/s10616-018-0274-9